Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Pfannschmidt

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
The Annals of Thoracic Surgery|January 28, 2010
Invited commentaryJoachim Pfannschmidt
Journal of Thoracic Disease|October 22, 2019
Expanding the knowledge of oligometastatic disease-but uncertainties remain significantJoachim Pfannschmidt
Journal of Thoracic Disease|April 3, 2018
Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?"Joachim Pfannschmidt
The Annals of Thoracic Surgery|December 23, 2006
Invited commentaryJoachim Pfannschmidt
The Annals of Thoracic Surgery|February 27, 2013
Invited commentaryJoachim Pfannschmidt
The Annals of Thoracic Surgery|May 26, 2009
Invited commentaryJoachim Pfannschmidt
Zentralblatt Fur Chirurgie|October 5, 2017
[Interdisciplinary Treatment of Patients with Pulmonary Tuberculosis]Joachim Pfannschmidt, Nicolas Schönfeld
Innovative Surgical Sciences|January 28, 2021
Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patientsSamantha Taber, Joachim Pfannschmidt
The Annals of Thoracic Surgery|November 27, 2012
Invited commentaryJoachim Pfannschmidt, Hendrik Dienemann
Lung Cancer (Amsterdam, Netherlands)|June 12, 2010
Surgical treatment of oligometastatic non-small cell lung cancerJoachim Pfannschmidt, Hendrik Dienemann
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
The Annals of Thoracic Surgery|January 28, 2010
Invited commentaryJoachim Pfannschmidt
Journal of Thoracic Disease|October 22, 2019
Expanding the knowledge of oligometastatic disease-but uncertainties remain significantJoachim Pfannschmidt
Journal of Thoracic Disease|April 3, 2018
Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?"Joachim Pfannschmidt
The Annals of Thoracic Surgery|December 23, 2006
Invited commentaryJoachim Pfannschmidt
The Annals of Thoracic Surgery|February 27, 2013
Invited commentaryJoachim Pfannschmidt
The Annals of Thoracic Surgery|May 26, 2009
Invited commentaryJoachim Pfannschmidt
Zentralblatt Fur Chirurgie|October 5, 2017
[Interdisciplinary Treatment of Patients with Pulmonary Tuberculosis]Joachim Pfannschmidt, Nicolas Schönfeld
Innovative Surgical Sciences|January 28, 2021
Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patientsSamantha Taber, Joachim Pfannschmidt
The Annals of Thoracic Surgery|November 27, 2012
Invited commentaryJoachim Pfannschmidt, Hendrik Dienemann
Lung Cancer (Amsterdam, Netherlands)|June 12, 2010
Surgical treatment of oligometastatic non-small cell lung cancerJoachim Pfannschmidt, Hendrik Dienemann
Pageof 5